- Home
- JD vs HLN Comparison
JD vs HLN Comparison
Compare JD & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JD
- HLN
- Stock Information
- Founded
- JD 2006
- HLN 2022
- Country
- JD China
- HLN United Kingdom
- Employees
- JD N/A
- HLN N/A
- Industry
- JD Other Specialty Stores
- HLN Package Goods/Cosmetics
- Sector
- JD Consumer Discretionary
- HLN Consumer Discretionary
- Exchange
- JD Nasdaq
- HLN Nasdaq
- Market Cap
- JD 47.4B
- HLN 45.6B
- IPO Year
- JD 2014
- HLN N/A
- Fundamental
- Price
- JD $33.86
- HLN $10.74
- Analyst Decision
- JD Strong Buy
- HLN Buy
- Analyst Count
- JD 10
- HLN 1
- Target Price
- JD $49.10
- HLN $10.95
- AVG Volume (30 Days)
- JD 13.9M
- HLN 15.0M
- Earning Date
- JD 05-13-2025
- HLN 02-27-2025
- Dividend Yield
- JD 2.89%
- HLN 1.56%
- EPS Growth
- JD 76.40
- HLN 38.94
- EPS
- JD 3.68
- HLN 0.20
- Revenue
- JD $158,761,901,950.00
- HLN $14,062,871,660.00
- Revenue This Year
- JD $9.85
- HLN $4.78
- Revenue Next Year
- JD $5.83
- HLN $4.75
- P/E Ratio
- JD $9.21
- HLN $27.01
- Revenue Growth
- JD 6.84
- HLN N/A
- 52 Week Low
- JD $24.13
- HLN $8.12
- 52 Week High
- JD $47.82
- HLN $10.80
- Technical
- Relative Strength Index (RSI)
- JD 42.05
- HLN 60.96
- Support Level
- JD $33.37
- HLN $10.57
- Resistance Level
- JD $34.65
- HLN $10.85
- Average True Range (ATR)
- JD 0.70
- HLN 0.14
- MACD
- JD 0.33
- HLN 0.05
- Stochastic Oscillator
- JD 68.21
- HLN 87.21
About JD JD.com Inc.
JD.com is the third-largest Chinese e-commerce platform by GMV in 2024. it offers a wide selection of authentic products with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.